PISCATAWAY, N.J., Jan. 21, 2025 /PRNewswire/ -- GenScript Biotech, a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies announced the successful conclusion of its 2025 JPM Global Forum held on January 15 in San Francisco. The event, themed "Challenges and Opportunities of Cell and Gene Therapy in the New Era," attracted more than 700 attendees both in person and via live-stream, featuring a series of keynote speeches and panel discussions that offered insights into the future of cell and gene therapy.